DR REDDYS
'1 ml of Cetirizine to an Infant Can Prove To Be Catastrophic': Dr Sivaranjani Santosh Who Fought Long Battle Against Misuse of ORS Label Urges Dr Reddy's To Withdraw Cetirizine From Market (Watch Video)
Layoffs at Dr Reddy’s Lab: Indian Drugmaker Cuts Workforce Costs by Nearly 25%, Laying Off Employees With Over INR 1 Crore Package, Says Report
Stocks To Buy or Sell Today, March 5, 2025: Adani Wilmar, Ola Electric Mobility, RVNL Among Shares That May Remain in Focus on Wednesday
Molnupiravir, COVID-19 Antiviral Drug, Launched in India at Rs 1,399 For Mild to Moderate Infection
Molnupiravir Capsules: Dr Reddy's Laboratories Gets DCGI's Nod to Launch Oral Anti-Viral Drug in India For Treatment of Adult Patients With COVID-19
'Made in India' Sputnik V COVID-19 Vaccine Doses to Be Available From September-October, Says Dr Reddy's Laboratories
Dr Reddy's Denied Approval for Phase 3 Trials of Sputnik Light COVID-19 Vaccine by Govt Panel
2-DG Update: Dr. Reddy's Laboratories Announces Commercial Launch of COVID-19 Drug 2-Deoxy-D-Glucose
COVID-19 Vaccine Update: Sputnik V Pilot in Final Leg in Mumbai, Bangalore and New Delhi; Scaled Up to Other Cities, Says Dr Reddy's Laboratories
2DG Price: DRDO's Anti-COVID-19 Drug Priced at Rs 990 Per Sachet; Centre, States to Get Discounts
Google Trends